Intervention Review

Prostanoids for critical limb ischaemia

  1. Antonio J Ruffolo1,*,
  2. Marina Romano2,
  3. Agustín Ciapponi3

Editorial Group: Cochrane Peripheral Vascular Diseases Group

Published Online: 20 JAN 2010

Assessed as up-to-date: 28 OCT 2009

DOI: 10.1002/14651858.CD006544.pub2

How to Cite

Ruffolo AJ, Romano M, Ciapponi A. Prostanoids for critical limb ischaemia. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD006544. DOI: 10.1002/14651858.CD006544.pub2.

Author Information

  1. 1

    Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina

  2. 2

    Hospital Italiano Buenos Aires, Neurology Department, CABA (Ciudad Autonoma de Buenos Aires), Buenos Aires, Argentina

  3. 3

    Institute for Clinical Effectiveness and Health Policy - Hospital Italiano de Buenos Aires, Argentine Cochrane Centre IECS - Family and Community Medicine Service, Buenos Aires, Capital Federal, Argentina

*Antonio J Ruffolo, Instituto de Efectividad Clínica y Sanitaria, Viamonte 2146, 3er piso, Buenos Aires, C1056ABH, Argentina.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 20 JAN 2010


Cited in:


This article has been cited by:

  1. 1
    Jean-Christophe Lega, Raphaèle Seror, Thomas Fassier, Olivier Aumaître, Isabelle Quere, Jacques Pourrat, Brigitte Gilson, Agnes Sparsa, Denis Wahl, Claire Le Jeunne, Olivier Decaux, Luc Mouthon, Alfred Mahr, Pascal Cohen, Loïc Guillevin, Christian Pagnoux, Characteristics, prognosis, and outcomes of cutaneous ischemia and gangrene in systemic necrotizing vasculitides: A retrospective multicenter study, Seminars in Arthritis and Rheumatism, 2014, 43, 5, 681


  2. 2
    A. Aiello, R. Anichini, E. Brocco, C. Caravaggi, A. Chiavetta, R. Cioni, R. Da Ros, M.E. De Feo, R. Ferraresi, F. Florio, M. Gargiulo, G. Galzerano, R. Gandini, L. Giurato, L. Graziani, L. Mancini, M. Manzi, P. Modugno, C. Setacci, L. Uccioli, Treatment of peripheral arterial disease in diabetes: A consensus of the Italian Societies of Diabetes (SID, AMD), Radiology (SIRM) and Vascular Endovascular Surgery (SICVE), Nutrition, Metabolism and Cardiovascular Diseases, 2014, 24, 4, 355


  3. 3
    C. Le Hello, Artériopathie oblitérante des membres inférieurs d’origine athéromateuse : évolution de la prise en charge en 2013, Archives des Maladies du Coeur et des Vaisseaux - Pratique, 2013, 2013, 221, 9


  4. 4
    Sanjay Misra, Robert Lookstein, John Rundback, Alan T. Hirsch, William R. Hiatt, Michael R. Jaff, Christopher R. White, Michael Conte, Patrick Geraghty, Manesh Patel, Kenneth Rosenfield, Proceedings from the Society of Interventional Radiology Research Consensus Panel on Critical Limb Ischemia, Journal of Vascular and Interventional Radiology, 2013, 24, 4, 451


  5. 5
    Tomoaki Ishihara, Yasunobu Yamashita, Naoko Takasaki, Shuhei Yamamoto, Erika Hayashi, Kayoko Tahara, Mitsuko Takenaga, Naoki Yamakawa, Tsutomu Ishihara, Tadashi Kasahara, Tohru Mizushima, Prostaglandin E1-containing nanoparticles improve walking activity in an experimental rat model of intermittent claudication, Journal of Pharmacy and Pharmacology, 2013, 65, 8
  6. 6
    Jill Belch, William R Hiatt, Iris Baumgartner, I Vickie Driver, Sigrid Nikol, Lars Norgren, Eric Van Belle, Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia, The Lancet, 2011, 377, 9781, 1929


  7. 7
    F Gerry R Fowkes, Jackie F Price, Gene therapy for critical limb ischaemia: the TAMARIS trial, The Lancet, 2011, 377, 9781, 1894


  8. 8
    Daniel G Cacione, Jose CC Baptista-Silva, Pharmacological treatment for Buerger's disease, The Cochrane Library,
  9. 9
    Lindsay Robertson, Alina Andras, Prostanoids for intermittent claudication, The Cochrane Library,